BEYOND THE GUIDELINES | DE-ESCALATION OF ANTIPLATELET THERAPY

Monday, March 9, 2026

4:00 PM - 5:15 PM EST

Location: Spotlight Theater

Moderator(s)

TBD Presenter, - coming soon

Faculty Coordinator
CRT 2026 | TBD
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Usman Baber, MD, MS

Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States

Disclosure information not submitted.
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Martine Gilard, MD,Phd

Professor
University of Brest
Brest, France

Disclosure(s): No financial relationships to disclose
Paul A. Gurbel, MD, FSCAI

Director
Sinai Center for Thrombosis Research and Drug Development
Baltimore, Maryland, United States

Disclosure information not submitted.
Adnan Kastrati, MD

Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Disclosure(s):

Dominick J. Angiolillo, MD, PhD, FSCAI: No financial relationships to disclose

Davide Capodanno, MD, PhD: Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Martine Gilard, MD,Phd: No financial relationships to disclose

Adnan Kastrati, MD: No financial relationships to disclose